Pablo Ruíz

1.6k total citations
54 papers, 615 citations indexed

About

Pablo Ruíz is a scholar working on Epidemiology, Surgery and Hepatology. According to data from OpenAlex, Pablo Ruíz has authored 54 papers receiving a total of 615 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 18 papers in Surgery and 18 papers in Hepatology. Recurrent topics in Pablo Ruíz's work include Liver Disease Diagnosis and Treatment (12 papers), Liver Disease and Transplantation (11 papers) and Organ Transplantation Techniques and Outcomes (11 papers). Pablo Ruíz is often cited by papers focused on Liver Disease Diagnosis and Treatment (12 papers), Liver Disease and Transplantation (11 papers) and Organ Transplantation Techniques and Outcomes (11 papers). Pablo Ruíz collaborates with scholars based in Spain, Italy and United States. Pablo Ruíz's co-authors include Gonzalo Crespo, Jordi Colmenero, Miquel Navasa, Lydia Sastre, Mercè Brunet, Xavier Forns, Asunción Moreno, Ezequiel Mauro, Alba Díaz and María‐Carlota Londoño and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and The Science of The Total Environment.

In The Last Decade

Pablo Ruíz

47 papers receiving 606 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pablo Ruíz Spain 13 248 243 152 142 70 54 615
Francesco Lupo Italy 18 334 1.3× 197 0.8× 341 2.2× 88 0.6× 109 1.6× 49 775
Martin‐Walter Welker Germany 13 507 2.0× 412 1.7× 115 0.8× 90 0.6× 29 0.4× 39 867
Yana Davidov Israel 7 115 0.5× 200 0.8× 101 0.7× 77 0.5× 12 0.2× 28 380
Maria Rendina Italy 17 604 2.4× 595 2.4× 217 1.4× 45 0.3× 68 1.0× 54 1.0k
Francesco Tandoi Italy 16 558 2.3× 380 1.6× 380 2.5× 112 0.8× 120 1.7× 56 869
Kazuhiko Sekiyama Japan 15 680 2.7× 527 2.2× 198 1.3× 77 0.5× 24 0.3× 27 913
Klaus S. Gutfreund Canada 14 764 3.1× 712 2.9× 200 1.3× 228 1.6× 79 1.1× 25 1.1k
Piyawat Komolmit Thailand 18 572 2.3× 472 1.9× 96 0.6× 153 1.1× 11 0.2× 84 818
Dolly Daniel India 15 165 0.7× 273 1.1× 124 0.8× 69 0.5× 64 0.9× 53 673
Montserrat Garcı́a-Retortillo Spain 17 1.6k 6.3× 1.4k 5.8× 204 1.3× 73 0.5× 60 0.9× 52 1.7k

Countries citing papers authored by Pablo Ruíz

Since Specialization
Citations

This map shows the geographic impact of Pablo Ruíz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pablo Ruíz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pablo Ruíz more than expected).

Fields of papers citing papers by Pablo Ruíz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pablo Ruíz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pablo Ruíz. The network helps show where Pablo Ruíz may publish in the future.

Co-authorship network of co-authors of Pablo Ruíz

This figure shows the co-authorship network connecting the top 25 collaborators of Pablo Ruíz. A scholar is included among the top collaborators of Pablo Ruíz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pablo Ruíz. Pablo Ruíz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pagano, Giulia, Salvatore Brugaletta, Annabel Blasi, et al.. (2025). Safety, efficacy, and outcomes of invasive coronary angiography in liver transplant candidates. JHEP Reports. 7(7). 101428–101428.
2.
Ferri, Valentina, Emilio Vicente, Yolanda Quijano, et al.. (2025). Predicting treatment response and survival in rectal cancer: insights from 18 FDG-PET/MRI post-neoadjuvant therapy. International Journal of Colorectal Disease. 40(1). 6–6.
3.
Mauro, Ezequiel, Marco Sanduzzi‐Zamparelli, Raquel García Sevila, et al.. (2024). Challenges in Liver Transplantation for Hepatocellular Carcinoma: A Review of Current Controversies. Cancers. 16(17). 3059–3059. 5 indexed citations
4.
Olivas, Pol, Valeria Pérez‐Campuzano, Lara Orts, et al.. (2023). Porto-sinusoidal vascular disorder in chronic HBV: A significant coexistence not to be overlooked. JHEP Reports. 6(3). 100996–100996. 4 indexed citations
5.
Ferri, Valentina, E. Vicente, Eduardo Díaz, et al.. (2023). The Predictive Value of 3D Imaging Reconstruction Models in Patients with Vascular Resection for Pancreatic Surgery. HPB. 25. S551–S552.
6.
7.
8.
Ferri, Valentina, Emilio Vicente, Yolanda Quijano, et al.. (2023). Light and shadow of watch-and-wait strategy in rectal cancer: oncological result, clinical outcomes, and cost-effectiveness analysis. International Journal of Colorectal Disease. 38(1). 277–277. 5 indexed citations
9.
López, Antonio, Pablo Ruíz, Vicent Yusà, et al.. (2023). Simultaneous direct determination of Glyphosate and AMPA in the ambient air and inhalation risk assessment in a Mediterranean Region (Spain). Atmospheric Environment. 317. 120204–120204. 4 indexed citations
10.
Cofán, Frederic, Pablo Ruíz, Javier Fernández, et al.. (2022). Primary herpes simplex virus type 1 infection with acute liver failure in solid organ transplantation: Report of three cases and review. IDCases. 28. e01485–e01485. 5 indexed citations
11.
Herrera, Sabina, Jordi Colmenero, Mariona Pascal, et al.. (2021). Cellular and humoral immune response after mRNA-1273 SARS-CoV-2 vaccine in liver and heart transplant recipients. American Journal of Transplantation. 21(12). 3971–3979. 68 indexed citations
12.
Ambrosioni, Juan, Montserrat Tuset, Mercè Brunet, et al.. (2021). Tacrolimus, Sirolimus and Everolimus Doses in HIV-Infected Solid-Organ Recipients, Requiring a Cobicistat-Based Antiretroviral Regimen: Report of Three Cases and Review. Infectious Diseases and Therapy. 10(2). 1055–1064. 5 indexed citations
13.
Ruíz, Pablo, et al.. (2020). Tocilizumab plus glucocorticoids in severe and critically COVID-19 patients. A single center experience. Medicina Clínica (English Edition). 155(9). 410–411. 2 indexed citations
14.
Córdoba, Borja Ruiz‐Fernández de, Urko Aguirre, Ana Estany‐Gestal, et al.. (2018). Only full adherence to proton pump inhibitors protects against drug-induced upper gastrointestinal bleeding. European Journal of Clinical Pharmacology. 74(11). 1503–1511. 5 indexed citations
15.
Sanclemente, G., Jordi Colmenero, Marta Español‐Rego, et al.. (2017). Mannose-Binding Lectin–Deficient Donors Increase the Risk of Bacterial Infection and Bacterial Infection–Related Mortality After Liver Transplantation. American Journal of Transplantation. 18(1). 197–206. 14 indexed citations
16.
Londoño, María‐Carlota, Christian Manzardo, Antoni Rimola, et al.. (2016). IFN-free therapy for HIV/HCV-coinfected patients within the liver transplant setting. Journal of Antimicrobial Chemotherapy. 71(11). 3195–3201. 6 indexed citations
17.
Ruíz, Pablo, et al.. (2013). Cost-Utility of Rheumatoid Arthritis Monotherapy with Tocilizumab in Spain. Value in Health. 16(7). A565–A565.
18.
Ruíz, Pablo, et al.. (2013). Comparison of INNO-LIPA and TRUGENE Assays for Genotyping and Drug-Resistance Mutations in Chronic Hepatitis B Virus Infection. Intervirology. 56(3). 190–194. 3 indexed citations
19.
Blanco, Sonia, et al.. (2009). Monitoring of therapy in patients with chronic hepatitis B virus. European Journal of Gastroenterology & Hepatology. 22(6). 1–1. 3 indexed citations
20.
Ruíz, Pablo, et al.. (2001). ¿Por qué un tratamiento precoz en la artritis reumatoide?. 11(6). 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francesco Lupo Breakdown of academic impact, for papers by Martin‐Walter Welker Breakdown of academic impact, for papers by Yana Davidov Breakdown of academic impact, for papers by Maria Rendina Breakdown of academic impact, for papers by Francesco Tandoi Breakdown of academic impact, for papers by Kazuhiko Sekiyama Breakdown of academic impact, for papers by Klaus S. Gutfreund Breakdown of academic impact, for papers by Piyawat Komolmit Breakdown of academic impact, for papers by Dolly Daniel Breakdown of academic impact, for papers by Montserrat Garcı́a-Retortillo
Rankless by CCL
2026